Everyone knows someone with cancer or that has died from cancer. It's
time for some new awareness...knowledge and real honesty about cancer,
treatment and recovery, not death from cancer and/or its treatment.
Please pass this blog on. Thank You & God Bless.
World's #1 Publisher of Information About Alternative Cancer Treatments
Your Solution For Disease FREE Health.
Continued From Last Post
The results presented demonstrate the rate of efficacy of CsCl in
cancer therapy. The total 50 cancer cases studied show an impressive 50%
survival rate. This confirms the work of Messiha reported in these
proceedings showing that the higher the dose it is, the more effective it
seems to be. The autopsy obtained from the patient whose death was
attributed to traumatic fracture of the neck, indicated that cancer had
been initially further advanced resulting in bone destruction. However,
the absence of cancer after the massive CsCl dose used in this case is
demonstrable of the Cs-therapy. It appears that both dosage, i.e., as
much as 30 grams/day and route of drug administration, i.e., nasogastric
pathway, might have contributed to the patients rapid recovery. It
should be noted, however, that CsCl dose regimens should not exceed 20 to
40 grams due to side effects, mainly nausea, and diarrhea. The authors
personal experience with CsCl after an acute dose of 40 grams CsCl
indicate that extensive nausea and parethesia around the mouth are the
major side effects. This is probably due to K depletion. The usual dose
used in the clinic ranges from 2 to 3 grams given by mouth 3 times daily.
At a later time, at which time there is no indication of cancer
presence, the CsCl dosage will be reduced to a preventative dose between
.5 and 1 gram a day.
The lymphoma case presented shows that CsCl efficiently reduced
massive enlargements of spleen and liver as well as maximal ascites,
causing an abdominal configuration of a tight, hard hemisphere, to almost
normalize after 3 months of therapy. This period of time was required to
eliminate such a massive volume resulting in the reduction of the body
The clinical efficacy of CsCl high pH metabolic therapy is best
demonstrated by a recent case of primary liver cancer (not included in
the 50 cases reported in this study). The patient was a 39 year old
female teacher who was terminal. She was brought on a stretcher on April
25, 1984 with a large liver tumor extending approximately 3 cm below the
umbilical level. The treatment was then immediately instituted. This
consisted of administration of CsCl, Beta-carotene, Vitamin C, Zn, Se,
Mn, Cr, and K salts by the oral route in addition to a concomitant
massive IV doses of ascorbate, K, Mg, Zn, Cn, Mn, Cr salts, B complex
vitamins, folic acid, DMSO and heparin. After 5 consecutive treatment
regimens EDTA was introduced to the therapy and the minerals present in
the solution were discontinued. On May 10, 1984, the patient was
discharged, returned home walking without assistance and displaying a
smile on her face. The liver tumor had shrunk to 5 cm above the
umbilicus. The determination of alphafetoprotein (AFP), a specific
marker for liver cancer, rare embronal cancer and teratomas, decreased
from the unusually high value of 39,000 units, compared to normal levels
of 13 units, measured before initiation of Cs-therapy, to 5000 units
obtained on the last day of treatment.
The mechanism of action of Cs in cancer has been little studied. Both
Cs+ and Rb+ can specifically enter the cancer cells and embryonic cells,
but not normal adult cells has been demonstrated by Brewer. The cancer
cells contain high amounts of hydrogen ions rendering them acidic and
they also contain high Na+ levels than found in normal cells. If Cs+ or
Rb+ can enter the cancer cells then the pH increases from as low as 5.5
to over pH 7.0. At a pH of 7.6 the cancer cell division will stop, at a
pH of 8.0 to 8.5 the lifespan of it is considerably shortened (only
hours). In one case, the author has observed the shrinkage of metastases
of breast cancer after one hour of Cs-treatment. Two days later wrinkles
of the skin appeared where the tumor was present. In another case of a
colon cancer with massive metastasis, of massive infiltration of the
abdominal wall, liver and other tissues, seemed to have been reduced
within 24 hours and continuing rapidly until the demise of the patient on
the 14th day of the Cs-treatment.
The uric acid levels measured at the onset of treatment was
approximately 3.5 units which was increased to over 20 units, suggesting
massive breakdowns of DNA, which produces the uric acid output.
Therefore, destruction of nuclear acids, as reflected by a significant
rise in the uric acid, may be used as a predictive measurement for
treatment outcome. The failure of uric acid elevation may be indicative
of lack of destruction of cancer cells. This has proven to be a very
consistent finding in our clinic.
There are certain factors which may enhance the Cs-therapy. The Cs-
penetration into the cancer cells can be increased by the following three
methods: The first approach resides in broadening the electron donor
capacity of the cancer cell membrane by the application of cyanide, an
electron donor radical as found in nitriles (amygdalin, Laetrile,
mandelonitrite, prunasin, ficin, cassivin), by selenium oxide, an
electron donor radical, or by the use of DMSO. The second approach
enhances the potential gradient across the cancer cell membrane by the
utilization of weak acids like ascorbic acid (Vitamin C) and retinoic
acid (Vitamin A). The third method attempts to improve the circulation
to the tumor and facilitate the destruction of cross-linkages in the
mucoid and fibrinous substances around the cancer cell. This can be
achieved by chelation therapy, i.e., the use of EDTA as has been shown by
Blumer who reported on the reduction of cancer incidence by 90% by
chelating patients (an average of 15 chelations in 8 years). This
approach also reduced cardiovascular disease by 50%. Other chelating
agents can also be used. Moreover, the use of beta-carotene will lead to
decomposition of blocking mucoid proteins mediated by electrical charges;
Also, heparin, which acts through electrical charges, will inactivate
the immune repelling and immune binding capacities of the blocking mucoid
proteins. These approaches will hinder cancer growth and they are
It should be noted that certain behavioral characteristics "the cancer
personality" of the cancer patient may interfere in any projected
treatment modality. This has been reported by Lawrence LeShan in his
book entitled "You can fight for your life." His studies suggested that
cancer patients seeking treatment, e.g., chemotherapy, radiation or
surgery, are probably motivated by a covert desire for death. For
example, statements such as, "rather than undergoing any of those
treatments, I would rather die in peace," or "I would never undergo any
of those treatments or let anyone of my family undergo them because the
effectiveness is unproven and the damage that is done with any of those
treatments is higher than the effects." are often expressed. Thus, both
chemotherapy and lifestyle changes may also contribute to an effective
God Bless Everyone & God Bless The United States of America.
42 S. Sherwood Dr.
Belton, Tx. 76513
Income for the 98% that fail in Their Internet Business.
Disclaimer...What you read on this site is opinion only. I am not
a doctor or any specialist in anything pertaining to this site. I'm
only a cancer survivor for over 5 years due to the alternative approach.
I did NOT follow the medical approach...I followed the alternative
approach to curing cancer. Now you know why I have a strong opinion.